130GENERAL GUIDELINES TO MINIMIZE DRUG INTERACTIONS IN THE TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN DIABETICSPatients with diabetes mellitus have a higher risk for hypertension, dyslipidemia and cardiovascular heart disease than does the general population. The focus of this article is minimizing drug interactions on therapy for hypertension, dyslipidemia in patients with diabetes. Pharmacologic approaches and controversies concerning the use of various classes of antihypertensive drugs including calcium channel blockers, beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers and diuretic therapy as well as antihyperlipidemic agents like statins, fibrates, resins are discussed in general as a tool for health care provider.gvpnraju2014@gmail.comReview722017Triglycerides,Cardiovascular heart disease,Angiotensin receptor blockersAnil Kumar KV,Beere NagarajuDepartment of Pharmacology, Visveswarapura Institute of Pharmaceutical Sciences, KIMS Hospital and Research Centre (Mentor Institute), Bangalore 560070, India.,Department of Pharmacology, Visveswarapura Institute of Pharmaceutical Sciences, KIMS Hospital and Research Centre (Mentor Institute), Bangalore 560070, India.